Back to Products
Product Details
Pack Size10x10 Tablets
FormTablets
Therapy AreaRenal Medicine - Diabetes
CategoryNephrology · Renal Medicine
Nephrology · Renal Medicine
DP GLIP
DPP-4 Inhibitor + Glipizide
Diabetic medication safe in CKD patients
Indication
Management of type 2 diabetes in patients with chronic kidney disease. Combination therapy for glycemic control in renal impairment.
Mode of Action
DPP-4 inhibitor enhances incretin effect, while glipizide stimulates insulin secretion. Combination provides effective glucose control with renal safety.
Dosage & Administration
As recommended or prescribed by a healthcare professional, nephrologist, transplant physician, or relevant specialist.
This information is for registered medical practitioner only. Anyone other than medical practitioner should consult medical practitioner before using this product.
.png)